28 March 2023: The annual general meeting of Aker BioMarine ASA will be held on
Thursday 20 April 2023 at 15:00 CET. 

The meeting will be conducted as a virtual meeting only, and voting will be
handled online during the meeting. Information about log-in details for the
meeting is available in the notice of
the general meeting. For further information regarding participation, please go
to www.akerbiomarine/agm.

No pre-registration is needed for attending online, but attendees must be logged
in before the meeting starts. Deadline for registration of advance votes and
proxies is 19 April 2023 at 16:00 CET.

Please find attached the following documents:
- Notice and proxy forms for the Annual General Meeting 2023
- Proposal from the Nomination Committee

All documents to be processed in the meeting are available on
www.akerbiomarine/agm.

For further information, please contact 
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email: Katrine.Klaveness@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for pharma, consumer health and
wellness as well as animal nutrition. The company has a strong position in its
industry and is the world's leading supplier of krill, the natural, powerful and
health promoting source of nutrients from the pristine waters of Antarctica.
Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is
available at www.akerbiomarine.com.